The aim of this study was to evaluate the possibility of using the anti-varicella zoster virus (anti-VZV, also known as anti-HSV3) vaccine against orobuccal herpes simplex virus type 1 (HSV1) and genital herpes simplex virus type 2 (HSV2). This was suggested by study of the phylogenetic tree of members of the herpes virus family, which showed a close relationship between VZV (HSV3) and the HSV1 and HSV2 herpes viruses. Methods: The present prospective study was conducted from January 2005 through January 2011. Twenty-four patients afflicted with HSV1 and HSV2 herpes recurrences over a period of years, numbering 6-8 and more recurrences per year, agreed to receive the anti-VZV vaccine. They were compared with 26 nonvaccinated patients presenting with herpes simplex diseases 2-5 times a year. All 50 patients were documented with anti-HSV1, anti-HSV2, and anti-VZV antibody serological testing. Results: From 2005 through 2011, for the 24 anti-VZV vaccinated patients, the average number of herpes relapses decreased to 0, correlated with an increased anti-VZV antibody level and clinical recovery of all patients, whereas no improvement was observed for the 26 nonvaccinated herpes patients. Conclusion: Data for the anti-VZV serological antibody levels tested before and after anti-VZV vaccination showed a significant (P , 0.001) increase among vaccinated patients. This suggests defective anti-VZV immune power in these patients. After 6 years of positive results for anti-VZV vaccine, this is a logical and fair hypothesis. We can now undertake a randomized study to confirm these findings.
La gestión de riesgos requiere análisis, contextualización y propuestas para responder a factores internos y externos que impactan la consecución de los objetivos y limitan el aprovechamiento de las oportunidades. Esta investigación tiene como propósito ofrecer a empresarios una recopilación de herramientas prácticas que podrán ser ejecutadas para implementar, gestionar y hacer seguimiento al análisis de los riesgos empresariales. Se realizó una revisión bibliográfica con base en el marco de referencia planteado por COSO ERM (2017), IIA (2013) y la ISO 31000:2018. Se realizó un estudio de caso en una empresa colombiana, dedicada a la producción y distribución de alimentos, donde se aplicó a los miembros de la alta dirección un instrumento que permitió conocer la severidad del riesgo, así como el valor Phi consultado a los miembros de la Junta Directiva. Se concluye que la gestión de riesgos pasa a ser una actividad de aplicación
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.